Biomics Biopharma (ASX:BBM) Other Long-Term Liabilities : A$0.00 Mil (As of . 20)

View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Other Long-Term Liabilities?

Biomics Biopharma's other long-term liabilities for the quarter that ended in . 20 was A$0.00 Mil.

Biomics Biopharma Other Long-Term Liabilities Historical Data

The historical data trend for Biomics Biopharma's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Other Long-Term Liabilities Chart

Biomics Biopharma Annual Data

Trend

Other Long-Term Liabilities

Biomics Biopharma Semi-Annual Data

Other Long-Term Liabilities

Biomics Biopharma Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Biomics Biopharma Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomics Biopharma (ASX:BBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Other Long-Term Liabilities

Comparable Companies

ASX:G88 ASX:ELS ASX:BHD ASX:IBX ASX:ZEN ASX:OLI ASX:KPG ASX:CAN ASX:MPW ASX:CQG ASX:OCA

Traded in Other Exchanges

N/A

Address

1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000

Website

http://www.biomics.com

Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines